Nukkleus Inc. (NASDAQ:DFNS – Get Free Report)’s stock price traded down 4.3% on Wednesday . The stock traded as low as $0.63 and last traded at $0.6386. 635,780 shares were traded during trading, a decline of 53% from the average session volume of 1,359,985 shares. The stock had previously closed at $0.6676.
Analysts Set New Price Targets
Separately, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Nukkleus in a report on Monday, March 23rd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.
Check Out Our Latest Analysis on Nukkleus
Nukkleus Stock Down 4.3%
Hedge Funds Weigh In On Nukkleus
Several institutional investors have recently bought and sold shares of the stock. BNP Paribas Financial Markets purchased a new position in Nukkleus during the second quarter valued at $56,000. State Street Corp grew its stake in Nukkleus by 70.7% during the fourth quarter. State Street Corp now owns 17,863 shares of the company’s stock valued at $72,000 after acquiring an additional 7,400 shares in the last quarter. Price T Rowe Associates Inc. MD purchased a new position in Nukkleus during the fourth quarter valued at $57,000. GM Advisory Group LLC purchased a new position in Nukkleus during the fourth quarter valued at $56,000. Finally, Millennium Management LLC purchased a new position in Nukkleus during the fourth quarter valued at $60,000. 12.47% of the stock is owned by hedge funds and other institutional investors.
Nukkleus Company Profile
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.
Featured Stories
Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.
